122 related articles for article (PubMed ID: 35963750)
1. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival.
van Hoeve JC; Verhoeven RHA; Nagengast WB; Oppedijk V; Lynch MG; van Rooijen JM; Veldhuis P; Siesling S; Kouwenhoven EA
Eur J Surg Oncol; 2023 Jan; 49(1):106-112. PubMed ID: 35963750
[TBL] [Abstract][Full Text] [Related]
2. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
3. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
4. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.
Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
[TBL] [Abstract][Full Text] [Related]
5. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
6. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
[TBL] [Abstract][Full Text] [Related]
7. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
8. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study.
Vermeulen BD; Bruggeman L; Bac DJ; Schrauwen RWM; Epping LSM; Scheffer RCH; Tan ACITL; Groenen MJM; Verhoeven RHA; Siersema PD
Acta Oncol; 2020 Apr; 59(4):410-416. PubMed ID: 32067535
[No Abstract] [Full Text] [Related]
9. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.
Luijten JCHBM; Vissers PAJ; Brom L; de Bièvre M; Buijsen J; Rozema T; Mohammad NH; van Duijvendijk P; Kouwenhoven EA; Eshuis WJ; Rosman C; Siersema PD; van Laarhoven HWM; Verhoeven RHA; Nieuwenhuijzen GAP; Westerman MJ
BMC Health Serv Res; 2022 Apr; 22(1):527. PubMed ID: 35449018
[TBL] [Abstract][Full Text] [Related]
10. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
[TBL] [Abstract][Full Text] [Related]
11. Trends in treatment and overall survival among patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
[TBL] [Abstract][Full Text] [Related]
12. Impact of diagnosis-to-treatment waiting time on survival in esophageal cancer patients - A population-based study in The Netherlands.
Visser E; van Rossum PS; Leeftink AG; Siesling S; van Hillegersberg R; Ruurda JP
Eur J Surg Oncol; 2017 Feb; 43(2):461-470. PubMed ID: 27847286
[TBL] [Abstract][Full Text] [Related]
13. Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands.
Reesink DJ; van de Garde EMW; van der Nat P; Somford DM; Los M; Horenblas S; van Melick HHE;
World J Urol; 2022 Jun; 40(6):1469-1479. PubMed ID: 35397692
[TBL] [Abstract][Full Text] [Related]
14. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
Seesing MFJ; van der Veen A; Brenkman HJF; Stockmann HBAC; Nieuwenhuijzen GAP; Rosman C; van den Wildenberg FJH; van Berge Henegouwen MI; van Duijvendijk P; Wijnhoven BPL; Stoot JHMB; Lacle M; Ruurda JP; van Hillegersberg R;
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31220859
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment.
Courrech Staal EF; van Sandick JW; van Tinteren H; Cats A; Aaronson NK
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):777-83. PubMed ID: 20554296
[TBL] [Abstract][Full Text] [Related]
16. Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study.
Faiz Z; Lemmens VE; Siersema PD; Nieuwenhuijzen GA; Wouters MW; Rozema T; Coebergh JW; Wijnhoven BP
World J Surg; 2012 Dec; 36(12):2872-8. PubMed ID: 22965535
[TBL] [Abstract][Full Text] [Related]
17. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
[TBL] [Abstract][Full Text] [Related]
18. Current status of radiotherapy for patients with thoracic esophageal cancer in Japan, based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society.
Toh Y; Numasaki H; Tachimori Y; Uno T; Jingu K; Nemoto K; Matsubara H
Esophagus; 2020 Jan; 17(1):25-32. PubMed ID: 31473871
[TBL] [Abstract][Full Text] [Related]
19. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists.
Verhoef C; van de Weyer R; Schaapveld M; Bastiaannet E; Plukker JT
Ann Surg Oncol; 2007 May; 14(5):1678-87. PubMed ID: 17294070
[TBL] [Abstract][Full Text] [Related]
20. Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study.
Al-Kaabi A; Baranov NS; van der Post RS; Schoon EJ; Rosman C; van Laarhoven HWM; Verheij M; Verhoeven RHA; Siersema PD
Acta Oncol; 2022 May; 61(5):545-552. PubMed ID: 35112634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
